USA - NASDAQ:DH - US24477E1038 - Common Stock
The current stock price of DH is 2.72 USD. In the past month the price decreased by -9.03%. In the past year, price decreased by -36.6%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.86 | 48.67B | ||
| DOCS | DOXIMITY INC-CLASS A | 31.07 | 9.54B | ||
| WAY | WAYSTAR HOLDING CORP | 27.54 | 7.04B | ||
| HTFL | HEARTFLOW INC | N/A | 2.98B | ||
| CERT | CERTARA INC | 16.56 | 1.33B | ||
| PHR | PHREESIA INC | N/A | 1.39B | ||
| SDGR | SCHRODINGER INC | N/A | 1.32B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.32B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.74 | 1.06B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 631.25 | 1.07B | ||
| CTEV | CLARITEV CORP | N/A | 965.47M |
Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. The company is headquartered in Framingham, Massachusetts and currently employs 782 full-time employees. The company went IPO on 2021-09-15. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. The company transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. Its business is conducted through AIDH TopCo, LLC (Definitive OpCo).
DEFINITIVE HEALTHCARE CORP
492 Old Connecticut Path, Suite 401
Framingham MASSACHUSETTS US
CEO: Jason Krantz
Employees: 782
Phone: 15087204224
Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. The company is headquartered in Framingham, Massachusetts and currently employs 782 full-time employees. The company went IPO on 2021-09-15. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. The company transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. Its business is conducted through AIDH TopCo, LLC (Definitive OpCo).
The current stock price of DH is 2.72 USD. The price decreased by -5.23% in the last trading session.
DH does not pay a dividend.
DH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
DEFINITIVE HEALTHCARE CORP (DH) currently has 782 employees.
DEFINITIVE HEALTHCARE CORP (DH) will report earnings on 2026-02-25, after the market close.
The outstanding short interest for DEFINITIVE HEALTHCARE CORP (DH) is 12.81% of its float.
ChartMill assigns a fundamental rating of 3 / 10 to DH. Both the profitability and financial health of DH have multiple concerns.
Over the last trailing twelve months DH reported a non-GAAP Earnings per Share(EPS) of 0.27. The EPS decreased by -20.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -39.57% | ||
| ROE | -100.37% | ||
| Debt/Equity | 0.53 |
21 analysts have analysed DH and the average price target is 4.57 USD. This implies a price increase of 67.92% is expected in the next year compared to the current price of 2.72.
For the next year, analysts expect an EPS growth of -33.05% and a revenue growth -4.79% for DH